Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-25-000047
Filing Date
2025-01-07
Accepted
2025-01-07 10:15:14
Documents
8
Period of Report
2025-01-07

Document Format Files

Seq Description Document Type Size
1 6-K zk2532514.htm 6-K 26521
2 EXHIBIT 5.1 exhibit_5-1.htm EX-5.1 10329
3 EXHIBIT 5.2 exhibit_5-2.htm EX-5.2 15929
4 EXHIBIT 10.1 exhibit_10-1.htm EX-10.1 198147
5 EXHIBIT 10.2 exhibit_10-2.htm EX-10.2 84080
6 EXHIBIT 10.3 exhibit_10-3.htm EX-10.3 86379
7 image00002.jpg GRAPHIC 3401
8 image00006.jpg GRAPHIC 9362
  Complete submission text file 0001178913-25-000047.txt   440378
Mailing Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871
Business Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35223 | Film No.: 25513722
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)